scispace - formally typeset
M

Makoto Nakazawa

Researcher at Johns Hopkins University

Publications -  181
Citations -  7808

Makoto Nakazawa is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Hemodynamics & Fontan procedure. The author has an hindex of 40, co-authored 181 publications receiving 7306 citations. Previous affiliations of Makoto Nakazawa include University of Iowa Hospitals and Clinics.

Papers
More filters
Journal ArticleDOI

Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study

TL;DR: In this article, the authors examined surgical, electrocardiographic, and late haemodynamic data, and their relation to clinical arrhythmia and sudden death occurring over 10 years, in a multicentre cohort of patients with repaired tetralogy.
Journal ArticleDOI

Role of TBX1 in human del22q11.2 syndrome

TL;DR: The results suggest that the TBX1 mutation is responsible for five major phenotypes in del22q11.2 syndrome, and conclude thatTBX1 is a major genetic determinant of the del22Q11.
Journal ArticleDOI

A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow.

TL;DR: The results indicated the validity of the PA-index in predicting the postoperative prognosis of the various entities and may also serve a useful guide in comparing surgical results from different institutions with patients having anomalies of varying severity.
Journal ArticleDOI

Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect

TL;DR: This work pinpoints essential sites of NKX2.5 in the development of the conduction system and observed some remarkable phenotypes, i.e., dextrocardia with E359Xfs and cribriform type ASD with R190C, both of which are expected to be clues for further investigations.
Journal ArticleDOI

Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system.

TL;DR: It is reported that mice lacking the Hesr1 gene are viable and fertile, whereas knockout mouse of both hesr1 and hesr2 is embryonic lethal at 11.5 days postcoitum and recapitulates most of the known cardiovascular phenotypes of disrupted Notch pathway mutants including defects in arterial-venous specification, septation and cushion formation.